Neuroprotective effect of atorvastatin in spinal cord ischemia-reperfusion injury

被引:16
作者
Nazli, Yunus [1 ]
Colak, Necmettin [1 ]
Alpay, Mehmet Fatih [1 ]
Uysal, Sema [2 ]
Uzunlar, Ali Kemal [3 ]
Cakir, Omer [1 ]
机构
[1] Univ Turgut Ozal, Sch Med, Dept Cardiovasc Surg, Ankara, Turkey
[2] Univ Fatih, Sch Med, Dept Biochem, Ankara, Turkey
[3] Univ Duzce, Sch Med, Dept Pathol, Duzce, Turkey
关键词
Atorvastatin; Spinal Cord; Ischemia-Reperfusion Injury; AORTIC-ANEURYSM REPAIR; NITRIC-OXIDE SYNTHASE; STATIN TREATMENT; BRAIN-INJURY; STROKE; PROTECTION; WITHDRAWAL; RECOVERY; MICE;
D O I
10.6061/clinics/2015(01)10
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: Prevention of the development of paraplegia during the repair of the damage caused by descending thoracic and thoracoabdominal aneurysms remains an important issue. Therefore, we investigated the protective effect of atorvastatin on ischemia-induced spinal cord injury in a rabbit model. METHOD: Thirty-two rabbits were divided into the following four equally sized groups: group I (control), group II (ischemia-reperfusion), group III (atorvastatin treatment) and group IV (atorvastatin withdrawal). Spinal cord ischemia was induced by clamping the aorta both below the left renal artery and above the iliac bifurcation. Seventy-two hours postoperatively, the motor function of the lower limbs of each animal was evaluated according to the Tarlov score. Spinal cord and blood samples were obtained for histopathological and biochemical analyses. RESULTS: All of the rabbits in group II exhibited severe neurological deficits. Atorvastatin treatment (groups III and IV) significantly reduced the level of motor dysfunction. No significant differences were observed between the motor function scores of groups III and IV at the evaluated time points. Light microscopic examination of spinal cord tissue samples obtained at the 72nd hour of reperfusion indicated greater tissue preservation in groups III and IV than in group II. CONCLUSION: This study demonstrates the considerable neuroprotective effect of atorvastatin on the neurological, biochemical and histopathological status of rabbits with ischemia-induced spinal cord injury. Moreover, the acute withdrawal of atorvastatin therapy following the induction of spinal cord ischemia did not increase the neuronal damage in this rabbit model.
引用
收藏
页码:52 / 60
页数:9
相关论文
共 32 条
[1]   Simvastatin protects against long-lasting behavioral and morphological consequences of neonatal hypoxic/ischemic brain injury [J].
Balduini, W ;
De Angelis, V ;
Mazzoni, E ;
Cimino, M .
STROKE, 2001, 32 (09) :2185-2191
[2]   Pharmacological approaches to repair the injured spinal cord [J].
Baptiste, DC ;
Fehlings, MG .
JOURNAL OF NEUROTRAUMA, 2006, 23 (3-4) :318-334
[3]   Prevention of Paraplegia during Thoracoabdominal Aortic Aneurysm Repair [J].
Bicknell, C. D. ;
Riga, C. V. ;
Wolfe, J. H. N. .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2009, 37 (06) :654-660
[4]   Stroke, statins, and cholesterol - A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors [J].
Blauw, GJ ;
Lagaay, AM ;
Smelt, AHM ;
Westendorp, RGJ .
STROKE, 1997, 28 (05) :946-950
[5]   Neuroprotective effect of N-acetylcysteine and hypothermia on the spinal cord ischemia-reperfusion injury [J].
Cakir, O ;
Erdem, K ;
Oruc, A ;
Kilinc, N ;
Eren, N .
CARDIOVASCULAR SURGERY, 2003, 11 (05) :375-379
[6]  
CORTAS NK, 1990, CLIN CHEM, V36, P1440
[7]   Morbidity and mortality after extent II thoracoabdominal aortic aneurysm repair [J].
Coselli, JS ;
LeMaire, SA ;
Conklin, LD ;
Köksoy, C ;
Schmittling, ZC .
ANNALS OF THORACIC SURGERY, 2002, 73 (04) :1107-1115
[8]   Atorvastatin prevents early apoptosis after thoracic spinal cord contusion injury and promotes locomotion recovery [J].
Dery, Marc-Andre ;
Rousseau, Guy ;
Benderdour, Mohamed ;
Beaumont, Eric .
NEUROSCIENCE LETTERS, 2009, 453 (01) :73-76
[9]  
DRAPER HH, 1990, METHOD ENZYMOL, V186, P421
[10]   Acute spinal cord injury, part I: Pathophysiologic mechanisms [J].
Dumont, RJ ;
Okonkwo, DO ;
Verma, RS ;
Hurlbert, RJ ;
Boulos, PT ;
Ellegala, DB ;
Dumont, AS .
CLINICAL NEUROPHARMACOLOGY, 2001, 24 (05) :254-264